Search - tctmd.com

Displaying 441 - 460 of 678

Sort: Relevancy | Date

Presentation TCT 2013

FFR in Non-Left Main Bifurcation Lesions

Presenter: Bon-Kwon Koo

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

Presentation TCT 2013

Case 4 : A Complex Bifurcation with Planned 2 Stents

Presenter: Alaide Chieffo

October 30, 2013

Presentation TCT 2013

Case 3: A Complex Bifurcation with a Provisional Second Stent Required

Presenter: John Ormiston

October 30, 2013

Presentation TCT 2013

Case 2: A Complex Bifurcation with Difficult side Branch Access

Presenter: Francesco Burzotta

October 30, 2013

Presentation TCT 2013

Case 1: A Complex Bifurcation Treated with 1 Stent

Presenter: Gennaro Sardella

October 30, 2013

Presentation TCT 2013

Case #2: Left Main Bifurcation Stenting: Do We Need a Dedicated Distal Left Main Stent?

Presenter: Ivo Petrov

October 30, 2013

Presentation TCT 2013

Case #11: In the Future Bifurcation Stents Will Disappear!

Presenter: Evald Christiansen

October 30, 2013

Presentation TCT 2013

Case #10: We Will Start Using Dedicated Bifurcation Devices!

Presenter: Niels Holm

October 30, 2013

Presentation TCT 2013

Build Future Bifurcation Strategies on Present Evidence

Presenter: Miroslaw Ferenc

October 30, 2013

Presentation TCT 2013

BVS in Bifurcations: One and Two Stent Options (With Case Examples)

Presenter: Vladimir Dzavik

October 30, 2013

Presentation TCT 2013

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

Presenter: Sung-Jin Hong

October 29, 2013

Presentation TCT 2013

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

Presenter: Toru Naganuma

October 29, 2013

Presentation TCT 2013

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Presenter: Robert Gil

October 29, 2013

Presentation TCT 2013

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

Presenter: Niels Holm

October 29, 2013

Presentation TCT 2013

TCT-25. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one- versus two-stent techniques versus double-kissing crush technique

Presenter: Yao-Jun Zhang

October 29, 2013

Presentation TCT 2013

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Presenter: Christoph Naber

October 29, 2013

Presentation TCT 2013

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Presenter: VG Patel

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

Presentation TCT 2013

Essential Strategies to Optimize Left Main and Non-Left Main Bifurcation Stenting

Presenter: Leif Thuesen

October 29, 2013

Advertisement

FFR in Non-Left Main Bifurcation Lesions

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Case 4 : A Complex Bifurcation with Planned 2 Stents

Case 3: A Complex Bifurcation with a Provisional Second Stent Required

Case 2: A Complex Bifurcation with Difficult side Branch Access

Case 1: A Complex Bifurcation Treated with 1 Stent

Case #2: Left Main Bifurcation Stenting: Do We Need a Dedicated Distal Left Main Stent?

Case #11: In the Future Bifurcation Stents Will Disappear!

Case #10: We Will Start Using Dedicated Bifurcation Devices!

Build Future Bifurcation Strategies on Present Evidence

BVS in Bifurcations: One and Two Stent Options (With Case Examples)

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

TCT-25. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one- versus two-stent techniques versus double-kissing crush technique

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

Essential Strategies to Optimize Left Main and Non-Left Main Bifurcation Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content